Stephens & Co. Maintains Overweight on Encompass Health, Raises Price Target to $78
Portfolio Pulse from richadhand@benzinga.com
Stephens & Co. analyst Scott Fidel maintains an Overweight rating on Encompass Health (NYSE:EHC) and raises the price target from $74 to $78.
June 29, 2023 | 2:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Encompass Health's price target has been raised from $74 to $78 by Stephens & Co. The firm maintains an Overweight rating on the stock.
The raised price target indicates that the analyst sees potential for the stock's price to increase. This could lead to positive sentiment among investors, potentially driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100